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Abstract: The ajenjo, Artemisia mendozanaDC. var.mendozana (Asteraceae), grows in the Andean foothills of Mendoza
and San Juan, Argentina, and is used as a medicinal plant for its antispasmodic and antifungal properties. The aim of this
work was to obtain fractions of a chloroform extract of ajenjo leaves and to evaluate the in vitro effects on proliferation,
viability and clonogenicity of B16-F0 melanoma cells. Using a silica gel chromatography column, 120 fractions were
collected and grouped according to the chromatographic profile in 9 main fractions (F1–F9). Their major compounds
identified were: terpenes (F1), terpenes and sesquiterpene lactones (F2–F3), sesquiterpenes (F4–F6) and phenols and
sesquiterpenes (F7-9). B16-F0 cells were incubated for 72 h with DMSO (vehicle) or 0.1 mg/ml F1–F9. At 72 h of
culture, F1 decreased both the growing index (GI) and cell viability. F2 and F3 both decreased GI and only F3
decreased clonogenic activity. F4 and F5 both decreased GI. Only F5 decreased cell viability and F4 decreased
clonogenicity. Consequently, fractions F6–F8 did not affect any of the cell parameters assayed, while F9 decreased cell
viability and inhibited clonogenicity.
Introduction
Argentina has a rich floral biodiversity; the native medicinal
flora consists of 1529 taxa. One hundred and fifteen of these
taxa are endemic and the Asteraceae is the richest family
among medicinal taxa and medicinal endemic species
(Barboza et al., 2009).
Artemisia is a genus of small herbs and shrubs found in
temperate regions. It belongs to the diverse family Asteraceae,
one of the most numerous plant groupings, which comprises
about 1000 genera and over 20000 species. Within this family,
Artemisia belongs to the tribe Anthemideae, which comprises
over 100 genera and more than 1200 species, mainly found in
Asia, Europe and America (Bora and Sharma, 2011).
Artemisia species are most commonly shrubs, rarely
perennial herbs and more rarely annual or biennial herbs.
Many Artemisia species have economic value in several
medical fields, as an antihelminthic (A. santonicum and
related taxa; Valles and McArthur, 2001), A. annua and A.
mexicana as antimalarial (Dhingra et al., 2000; Malagon et
al., 1997). Artemisinin (obtained from A. annua) selectively
kills human breast cancer cells (Singh and Lai, 2001).
Artemisia mendozana DC mendozana (Fig. 1), popularly
known as ajenjo, is a medicinal plant of the Andean foothills
of Mendoza and San Juan provinces, Argentina (Márquez,
1999). Leaves, flowers and shoots are employed in folk
medicine as infusions to treat liver and stomach aches
(Bustos et al., 1996). The antibacterial properties of the
ethanolic extract of A. mendozana inhibited in vitro the
growth of several Gram-positive and Gram-negative bacteria
(Feresin et al., 2000); also the essential oil of A. mendozana
has antiviral (Duschatzky et al., 2005) and trypanocidal
activities (Cimador et al., 2019).
The aim of this work was to test the in vitro effects of
fractions of an ajenjo chloroform extract on the proliferation,
viability and clonogenicity of mouse melanoma B16-FO cells.
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Aerial parts from wild plants of ajenjo. A. mendozana DC var.
mendozana, were collected in the hills near the Potrerillos
town (Luján de Cuyo, Mendoza: 32°57’S, 69°11’W, ~1400
masl) on April 2016. A voucher specimen was deposited at
the Herbarium Ruiz Leal (MERL) under n° 38214.
Chloroform extract
Ajenjo leaves (300 g) were washed with chloroform for 20 s and
the chloroform suspension was dried to obtain a chloroform
crude extract pellet. In order to partially eliminate phenolic
compounds from the extract, the pellet was suspended with
chloroform and alkalized with 1% sodium hydroxide (pH =
8). A colored upper phase of phenolic salts was removed and
the suspension was acidified with hydrochloric acid (1%),
washed with distilled water and dried in a rotary evaporator.
The pellet containing a high concentration of medium
polarity compounds (medium polarity compounds pellet) was
loaded to a silica gel chromatography column.
Silica gel chromatography
Afterwards, 1.5 g of medium polarity compounds pellet were
suspended in 5 ml of mobile phase (5:2 v/v hexane : ethyl
acetate) and seeded in a column containing 33 g of Silica gel
(230–400 mesh) equilibrated with petroleum ether. The
separation was performed isocratically with the mobile
phase. Column fractions of 5 ml each were collected and
analyzed by thin layer chromatography (TLC). Eluted
fractions were grouped according to the similarity of their
chromatographic profiles in main fractions. Retention factor
(Rf), distance traveled by the spot/distance traveled by
mobile phase, were established for each spot for the purpose
of comparing the fractions obtained.
Thin layer chromatography (TLC)
Aluminum sheets, 10 × 10 cm Silica gel 60 F254 with fluorescent
indicator UV254 (Merck, Germany), were loaded with 2 µL of
each fractions and cholesterol (employed as Rf reference); a
mixture of hexane: ethyl acetate (5:3, v/v) was employed as
mobile phase. The chromatograms were visualized under UV
254 nm and a solution of p-anisaldehyde was employed for
the chemical identification of spots.
Cells, treatments and assays
B16-F0 murine melanoma cells were a kind gift of Dr. Gabriel
Rabinovich (IBYME, CONICET, Buenos Aires). They were
cultured in RPMI medium (RPMI1640 medium (Gibco,
USA) supplemented with 10% fetal bovine serum (FBS), 50
U/ml of penicillin, 50 μg/ml streptomycin, 50 μg/ml
ciprofloxacin) in a humidified incubator with 5% CO2 at 37°
C. Cells were harvested after reaching a confluence of 70–
80% and 1 × 104 cells were plated in 12 well plates with
RPMI medium and left for 15 h for adhesion.
For cell proliferation, viability and clonogenic survival
assays, the medium was removed, the cells washed with
PBS, incubated with RPMI medium and treated with 10 μl
of 10 mg of main fractions/ml of DMSO (0.1 mg/ml final
fraction concentration) 72 h. For controls, 10 μl of the
vehicle (DMSO) was added.
For cell proliferation assays a direct cell count in each
well was made every 24 h, during 72 h since the start of
treatments, using a Nikon Eclipse TE 2000U inverted
microscope (Nikon, Japan), by means of a 20× objective
lens. Five independent experiments were performed. The
results were expressed as the growing index (GI, number of
cells found in a particular case over the number of cells
seeded at time 0 of treatment).
For clonogenic survival assay, cells that had been treated
for 72 h, were trypsinized, and were seeded in 12 well
multiwell plates (250 cells/well) and were cultured in RPMI
medium for 10 days (at this time the colonies were large
enough to be clearly appreciated). Then the colonies were
fixed with 100% methanol for 30 min, and were stained
with a filtered 0.5% crystal violet water solution (Sigma-
Aldrich, USA) for 10 min, washed, and counted. Percent
clonogenicity was calculated as the number of colonies over
number of cells seeded, times 100. Three independent
experiments were performed.
For cell viability assays, 5 × 103 B16-F0 cells/well were
seeded in 96 well multiwell plates and treated 72 h as
mentioned above. For MTT [3-(4, 5-dimethylthiazol-2-yl)-2,
5-diphenyltetrazolium bromide] assay, cells were washed with
PBS and 0.2 ml RPMI medium containing 0.5 mg/ml MTT
(Sigma-Aldrich, USA) was added to each well and incubated
at 37°C for 2 h. Then, DMSO was added to dissolve the
MTT-derived formazan which was quantified by measuring
the absorbance at 562 nm wavelength (Liu et al., 1997).
Statistical analysis
The data shown are the mean ± SEM of 3–5 independent
experiments. Statistical analysis was performed using 2-way
ANOVA and 2-tails Student’s t test (Prism 5, GraphPad
Software Inc., USA). The differences were considered
significant for: *p < 0.05, **p < 0.01, ***p < 0.001.
Results
Fractions obtained by column chromatography of chloroform
extract
One hundred and twenty fractions, 5 mL each, were collected
and the fractions showing a similar chromatographic profile on
TLC were mixed and the solvent evaporated to yield 9z main
fractions (dubbed as main fractions F1–F9) (Figs. 2A and 2B).
The qualitative composition and relative quantity of main
fractions F1–F9 are shown in Tab. 1. A first observation under
UV 245 nm (Fig. 2A) and after the chemical development
(Fig. 2B) indicated the following: main fraction F1 presented
a blue spot with 90% relative intensity (RI) of Rf = 0.96,
corresponding to terpenes (Fig. 2B, line 1. Main fractions F2
and F3 showed two spots, one of terpenes (blue colored, Rf =
0.96) and the other of sesquiterpene lactones (brown colored,
Rf = 0.64). RIs corresponded to 30% and 40% terpenes and
60% and 70% sesquiterpene lactones for the main fractions
F2 and F3 respectively (Fig. 2B, lines 2, 3). Main fractions F4
and F5 showed a purple spot (Rf = 0.44), corresponding to
sesquiterpenes. RIs were 70% and 85% of sesquiterpenes for
F4 and F5, respectively (Fig. 2B, lines 4, 5). Main fraction F6
also showed a purple spot of sesquiterpenes, and another
unidentified spot (gray, 0.30 Rf) (Fig. 2B, line 6). Main
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FIGURE 2. TLC of main fractions of the ajenjo chloroform extract. (A,
B) Chromatogram of F1–F9, cholesterol employed as reference
substance. (A) Plate visualized under at UV-254 nm and (B) plate
revealed with p-anisaldehyde. Rf positions (Rf = 0.64, Rf = 0.44 and
Rf = 0.33) are indicated.
TABLE 1


















2 29–34 30% Terpenes (Rf = 0.96)
70% Sesquiterpene lactones (Rf = 0.68)
Decreased No changed No changed
3 35–44 40% Terpenes (Rf = 0.96)
60% Sesquiterpene lactones (Rf = 0.68)
Decreased No changed Decreased
Sesquiterpenes 4 45–53 70% Sesquiterpenes (Rf = 0.44) Decreased No changed Decreased
5 54–61 85% Sesquiterpenes (Rf = 0.44) Decreased Decreased No changed
6 62–71 60% Sesquiterpenes (Rf = 0.44)
40% Unidentified compounds (Rf = 0.30)
No changed No changed No changed
Sesquiterpenes-
phenols
7 72–80 50% Sesquiterpenes (Rf = 0.44)
50% phenols (Rf = 0.33)
No changed No changed No changed
8 81–96 10% Sesquiterpenes (Rf = 0.44)
50% phenols (Rf = 0.33)
40% Unidentified compounds (Rf = 0.24)
No changed No changed No changed
9 97–120 10% Sesquiterpenes (Rf = 0.44)
30% Phenols (Rf = 0.33)
60% Unidentified compounds (Rf = 0.24)
Decreased Decreased Decreased
FIGURE 1. Aerial parts of ajenjo, Artemisia mendozana DC. var.
mendozana.
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fraction F7 also showed a purple spot of sesquiterpenes (50%)
and another Rf = 0.33 yellow spot of phenols (Fig. 2B, line 7).
Finally, main fractions F8 and F9 contain sesquiterpenes
(10% in both), phenols (50% and 30% respectively) and a Rf =
0.24 green spot of unidentified compounds (40% and 60%
respectively) (Fig. 2B, lines 8, 9).
According to the characteristic of the compounds in the
main fractions (see Fig. 2 and Tab. 1), they were classified in 4
groups: terpenes group (F1), terpenes-sesquiterpene lactones
group (F2–F3), sesquiterpenes group (F4–F6) and
sesquiterpenes-phenols group (F7–F9).
With the purpose of analyzing whether main fractions
alter cell proliferation, cell viability and clonogenic
capacity, B16-F0 cells were separately cultured in presence
of each of the nine main fractions. The main results were
summarized in Tab. 1.
FIGURE 3.Main fractions of the ajenjo chloroform extract inhibit B16-F0 cell proliferation. (A, B) B16FO cells were incubated with 0.10 mg/ml of
fractions: F1 (a), F2 (b), F3 (c), F4 (d), F5 (e), F6 (f), F7 (g), F8 (h), F9 (i) and with DMO, for 72 h and counted every 24 h. (A) The number of cells was
expressed as a growing index (GI) (number of cells at a given time/number of cell at 0 time of incubation). Data are the mean ± SE of 5 independent
experiments *p < 0.05, **p < 0.01, ***p < 0.001 vs. control group (10 μl DMSO). (B) Representative images of the cells at 72 h of treatment.
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Effect of terpenes group (F1)
The treatment of B16-F0 cell with F1 decreased both GI (36%)
(Fig. 3A,a) and cell viability (53%) (Fig. 4a), indicating that the
F1 containing terpenes (90% RI) inhibited cell proliferation
and generated cell dead.
Effects of terpene-sesquiterpene lactones group (F2 and F3)
The treatment of B16-F0 cell with F2 and F3 both decreased
GI (40% and 56% respectively) (Fig. 3A,b,c) and only F3
decreased clonogenic activity (43.9%) (Figs. 5A and 5B, F3).
These results indicate that the combination of terpenes and
sesquiterpene lactones inhibit cell proliferation. It is deemed that
the inhibition of cell proliferation and the decrease of
clonogenicity require a terpenes relation higher than 30% RI.
Effects of sesquiterpenes group (F4–F6)
The treatment of B16-F0 cell with F4 and F5 both decreased GI
(51% and 47% respectively) (Fig. 3A,d,e). Only F5 decreased cell
viability 58% (Fig. 4e) and F4 decreased clonogenicity (15.1%)
(Figs. 5A and 5B, F4). F6 did not affect any parameter assayed
(Figs. 3A,f, 4f, 5A and 5B, F6). These results indicate that
sesquiterpenes in a RI of 85% (as those in F5) are needed to
inhibit cell proliferation and generate cell dead.
F4, which contained 70% RI of sesquiterpenes (Tab. 1)
inhibited cell proliferation and affected cell clonogenicity, while
F5, containing 85% RI of sesquiterpenes (Tab. 1) inhibits cell
proliferation and also affected cell viability. Apparently, a
sesquiterpene higher RI than 70%was needed to affect cell viability.
Regarding F6, which contained 60%RI of sesquiterpenes and
40% RI of unidentified compounds (Rf = 0.3) (Tab. 1) did not
inhibit cell proliferation nor cell clonogenicity. Also, F6 did not
affect cell viability. It is possible that a high RI of sesquiterpenes
are needed to alter these cellular parameters, because F5 has
higher RI of sesquiterpenes (60%) than that of F6, and that only
F5 inhibited cell proliferation and cell clonogenicity. Another
possibility is that the unidentified compounds (0.3 Rf) in F6,
may interfere with sesquiterpene activity.
Effects of sesquiterpenes-phenols group (F7–F9)
Only F9 decreased cell viability (43%) (Fig. 4i) and inhibited
clonogenicity (9.3%) (Figs. 5A and 5B, F9). Neither a high
IR of sesquiterpenes in F7 (50%) nor a high IR of phenols
in F8 (50%) had effect in the cell parameters assayed. Then,
it is possible that the unidentified compound (Rf = 0.24)
found in F9, with 60% RI, inhibited both cell viability and
clonogenicity. It is possible that same cells died in apoptosis
and others were arrested in senescence. It is interesting to
mention that cell treated with F9 had an increased cell size
(Fig. 3B,i) and it is known that senescent cells look flat and
with an enlarged cytoplasm (Hwang et al., 2009).
FIGURE 4. Main fractions of the ajenjo chloroform extract inhibit B16-F0 cell viability. B16FO cells were incubated with 0.10 mg/ml of
fractions: F1 (a), F2 (b), F3 (c ), F4 (d), F5 (e), F6 (f), F7 (g), F8 (h), F9 (i) and with DMSO, for 72 h. Every 24 h MTT-derived formazan
was assayed at 562 nm wavelength. Data are expressed as the absorbance (562 nm) mean ± SE of 4 independent experiments *p < 0.05, **p <
0.01, ***p < 0.001 vs. control group (DMSO).
ANTITUMOR ACTIONS OF AJENJO EXTRACT FRACTIONS 5
Discussion
Although the studies with Artemisia species show
predominantly the bioactivity of fractions with a single type
of medium polarity compounds, as sesquiterpene lactones,
the effects of two types of compounds together were also
shown. This is in parallel with the known interaction of
phenolic compounds (flavonoids) with artemisinin, which
improves the effectiveness of the treatment of parasitic
diseases such as malaria and cancer (Ferreira et al., 2010).
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